Saltar al contenido
ACMG/AMP · 20,000+ genes · From €300

Genetic diagnosis with clinical exome

Whole exome sequencing with ACMG/AMP classification of variants. The reference diagnostic tool for genetic diseases of unknown cause.

20,000+ genes analysed
100x mean coverage
4–6 weeks turnaround
ACMG/AMP current classification
Clinical indications

When is an exome requested?

The clinical exome is indicated when there is suspicion of a genetic disease without an established molecular diagnosis, especially in complex or poorly specific phenotypes.

Developmental delay

Psychomotor delay, intellectual disability, autism spectrum disorders and multiple congenital anomalies.

Epilepsy

Early epileptic encephalopathies, refractory epilepsies and conditions with complex neurological phenotype.

Hereditary cardiopathies

Cardiomyopathies, channelopathies, aortopathies and congenital heart disease with family history.

Infertility

Male or female infertility with previous negative panels and suspicion of monogenic aetiology.

Deafness

Congenital sensorineural hearing loss, syndromic and non-syndromic deafness with inconclusive panels.

Metabolic diseases

Inborn errors of metabolism, lysosomal storage diseases and suspicion of mitochondriopathies.

Scope of the analysis

What a clinical exome analyses

We cover all coding regions of the genome and the clinically relevant adjacent intronic zones.

  • Coding regionsAll 20,000+ human genes with their exons and intron/exon boundaries ±10 bp.
  • Single nucleotide variants (SNV)Single nucleotide changes with Q30>90% quality and mean depth of 100x.
  • IndelsSmall insertions and deletions (<50 bp) validated with high-sensitivity callers.
  • Exonic CNVDeletions and duplications of one or more exons detected by read depth.
  • Splicing variantsIn silico analysis with SpliceAI and specific predictors for deep intronic variants.
  • Annual reanalysisOption to reanalyse upon changes in the knowledge base (ClinVar, HGMD, OMIM).
Process

The process, step by step

From consent to signed clinical report in a maximum of six weeks.

Medical prescription

The clinician requests the study with the phenotype coded in HPO terms and the informed consent.

Sample collection

2 EDTA K2 blood tubes or saliva. Free refrigerated courier included.

DNBSEQ sequencing

Exome capture, PE150 sequencing at 100x and bioinformatics analysis with a validated pipeline.

Report + counselling

Report signed by clinical geneticist and genetic counselling session included.

Advantages

Why our exome

  • ACMG/AMP classificationEach variant according to current international guidelines, with explicit criteria.
  • Uniform >100x coverageSufficient depth for reliable detection of mosaicism and complex heterozygous variants.
  • Trio analysis availableExome of patient and both parents for segregation filtering and de novo detection.
  • Integrated CNVDetection of structural variants from the same data, without additional MLPA or array.
  • Genetic counsellingIn-person or telematic session included with clinical geneticist.
  • Upgradeable to WGSIf the exome is inconclusive, we scale up to whole genome without a new sample.
Pricing

Complete clinical exome

Do you have a clinical case to discuss?

Our team of clinical geneticists reviews complex phenotypes and advises on the most appropriate test.

Contact us Order exome
OmicaLabs